文献速递胸部肿瘤

靶向DHX9在小细胞肺癌中触发肿瘤内在干扰素反应与复制应激

Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer.
PubMed 文献 · Cancer Discov · 2024-01-01

研究通过CRISPR筛选发现DHX9是小细胞肺癌中双链RNA的抑制因子。敲除DHX9可诱导胞质双链RNA积累并激活肿瘤内在天然免疫,同时引起R环异常积累、胞质DNA增多和复制应激。体内实验显示DHX9缺失抑制肿瘤生长、改善免疫微环境并增强免疫检查点阻断疗效。

要点

  • CRISPR筛选鉴定DHX9为小细胞肺癌中双链RNA的强效抑制因子。
  • 敲除DHX9诱导胞质双链RNA积累并触发肿瘤内在天然免疫。
  • DHX9缺失引起R环异常积累、胞质DNA增多和复制应激,并增强免疫检查点阻断疗效。

核心结论

  • DHX9是肿瘤内在天然免疫和复制应激的关键抑制因子,是有望靶向小细胞肺癌及其他基因组不稳定相关「冷」肿瘤的靶点。

研究设计与样本

  • 基于CRISPR的RNA解旋酶筛选,鉴定DHX9为小细胞肺癌中双链RNA的抑制因子。

主要发现

  • 敲除DHX9诱导胞质双链RNA积累并触发肿瘤内在天然免疫。
  • 敲除DHX9引起R环异常积累,导致胞质DNA增多和复制应激增加。
  • 体内DHX9缺失抑制肿瘤生长,诱导更具免疫原性的肿瘤微环境,并增强对免疫检查点阻断的应答。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Activating innate immunity in cancer cells through cytoplasmic nucleic acid sensing pathways, a phenomenon known as "viral mimicry," has emerged as an effective strategy to convert immunologically "cold" tumors into "hot." Through a curated CRISPR-based screen of RNA helicases, we identified DExD/H-box helicase 9 (DHX9) as a potent repressor of double-stranded RNA (dsRNA) in small cell lung cancers (SCLC). Depletion of DHX9 induced accumulation of cytoplasmic dsRNA and triggered tumor-intrinsic innate immunity. Intriguingly, ablating DHX9 also induced aberrant accumulation of R-loops, which resulted in an increase of DNA damage-derived cytoplasmic DNA and replication stress in SCLCs. In vivo, DHX9 deletion promoted a decrease in tumor growth while inducing a more immunogenic tumor microenvironment, invigorating responsiveness to immune-checkpoint blockade. These findings suggest that DHX9 is a crucial repressor of tumor-intrinsic innate immunity and replication stress, representing a promising target for SCLC and other "cold" tumors in which genomic instability contributes to pathology. SIGNIFICANCE: One promising strategy to trigger an immune response within tumors and enhance immunotherapy efficacy is by inducing endogenous "virus-mimetic" nucleic acid accumulation. Here, we identify DHX9 as a viral-mimicry-inducing factor involved in the suppression of double-stranded RNAs and R-loops and propose DHX9 as a novel target to enhance antitumor immunity. See related commentary by Chiappinelli, p. 389. This article is featured in Selected Articles from This Issue, p. 384.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Murayama T, Nakayama J, Jiang X, et al. Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer. Cancer Discov. 2024. PMID: 38189443. doi:10.1158/2159-8290.CD-23-0486

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。